Global Fund grant - Project DR-TB PDF Печать


The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) is a 21st-century partnership organization designed to accelerate the end of AIDS, tuberculosis and malaria as epidemics.


Founded in 2002, the Global Fund is a partnership between governments, civil society, the private sector and people affected by the diseases. The Global Fund raises and invests nearly US$4 billion a year to support programs run by local experts in countries and communities most in need.


International technical support project "Ensuring universal access to rapid laboratory diagnosis of drug resistant tuberculosis (DR-TB) and universal coverage of DR-TB patients with high-quality treatment" was registered in the database of international technical support programs and projects on 29.12.2015 No. 2/15/000785.

The current grant aims to reduce the burden of tuberculosis in Belarus by ensuring universal access to rapid laboratory diagnosis of TB and M/XDR-TB and universal coverage of M/XDR-TB patients with high-quality treatment, through strengthening patient- centered approaches in outpatient conditions, and strengthening management, monitoring and evaluation of the NTP. This grant covers the needs of population from both civilian and penitentiary sectors.

Target Group:

·       TB, MDR-TB, pre-XDR and XDR patients;

·       Prisoners;

·       TB/HIV patients People affected by TB.


·       To ensure universal access to high-quality rapid laboratory diagnosis of all forms of TB, including M/XDR-TB;

·       To enhance coverage of M/XDR-TB patients with high-quality treatment;

·       To improve MDR-TB treatment outcomes with appropriate patient-centred support, including patients from high-risk groups and vulnerable populations;

·       To improve management of HIV-associated tuberculosis;

·       Health system strengthening by introducing new funding models of the ambulatory TB care;

·       To strengthen national monitoring and evaluation system, NTP management for improved performance of TB control program.


·       Prevention, case detection and diagnosis, and treatment of MDR-TB;

·       Collaborative activities and other programs and sectors;

·       Service organization and facility management;

·       Routine reporting;

·       Surveys;

·       Analysis, review, and transparency;

·       Supporting procurement and supply management;

·       Institutional capacity building, planning and leadership development.